MRM
Medirom Healthcare Technologies Inc
NASDAQ: MRM · CONSUMER CYCLICAL · PERSONAL SERVICES
$1.03
-5.04% today
Updated 2026-06-05
Market cap
$8.93M
P/E ratio
3.05
P/S ratio
0.00x
EPS (TTM)
$0.37
Dividend yield
—
52W range
$1 – $4
Volume
0.4M
WallStSmart proprietary scores
39
out of 100
Grade: D
Sell
Investment rating
4.0
Growth
C4.0
Quality
C4.5
Profitability
C8.3
Valuation
A3/9
Piotroski F-Score
Weak
0.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$5.12
+397.09%
12-Month target
$1.37
+33.01%
Intrinsic (DCF)
$3.46
Margin of safety
+62.43%
Price chart
Stock snapshot
Strengths
+ ROE 63.91% — strong efficiency
+ 62.43% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 0.93 — distress zone
- Thin margins at 0.50%
- Negative free cash flow $-358.04M
- Revenue declining -6.70% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $6.95B | $6.83B | $8.30B | $4.04M | $8.07B |
| Net income | $148.97M | $115.05M | $148.76M | $374720.00 | $63.43M |
| EPS | — | — | — | — | $0.37 |
| Free cash flow | $-671.01M | $-806.44M | $-767.58M | $-1.90B | $-358.04M |
| Profit margin | 2.14% | 1.68% | 1.79% | 9.27% | 0.50% |
Peer comparison
Smart narrative
Medirom Healthcare Technologies Inc trades at $1.03. representing a P/E of 3.05x trailing earnings. Our Smart Value Score of 39/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 0.93, it sits in the distress. TTM revenue stands at $8.07B. with profit margins at 0.50%. Our DCF model estimates intrinsic value at $3.46.
Frequently asked questions
What is Medirom Healthcare Technologies Inc's stock price?
Medirom Healthcare Technologies Inc (MRM) trades at $1.03, on a P/E of 3.1x and a P/S of 0.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Medirom Healthcare Technologies Inc overvalued?
Medirom Healthcare Technologies Inc carries a Smart Value Score of 39/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $3.46 versus the $1.03 price, a 62.4% margin of safety on a cash flow basis.
What is the price target of Medirom Healthcare Technologies Inc (MRM)?
The 12-month analyst consensus target is $5.12, about 397.1% above the current $1.03. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Medirom Healthcare Technologies Inc (MRM)?
Our DCF model estimates intrinsic value at $3.46, a +62.4% margin of safety versus today's $1.03. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Medirom Healthcare Technologies Inc's revenue?
Medirom Healthcare Technologies Inc's trailing twelve-month revenue is $8.07B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Medirom Healthcare Technologies Inc's Altman Z-Score is 0.93, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorCONSUMER CYCLICAL
IndustryPERSONAL SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.00x
ROE63.91%
Beta1.00
50D MA$1.13
200D MA$1.66
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—